WARNING: We do not support Internet Explorer. It is not secure and will not work correctly. Please come back using a newer web browser.


Laboratory Support for Pain Management Programs, 1st Edition

This guideline provides recommendations for medical laboratories and clinical practices that provide services for pain management.

This reaffirmed document has been reviewed and confirmed as suitable to remain published without revision to content, as of January 2023. The document’s next scheduled review is generally five years after the reaffirmation date.

Member price:

List Price:
Log in/sign up to see price and add to cart


Chairholder: Catherine A. Hammett-Stabler, PhD, DABCC, FACB

Date of Publication: May 31, 2018

Order Code PDF: CLSI C63Ed1E
ISBN Number: 978-1-68440-003-4

Order Code Print: CLSI C63Ed1
ISBN Number: 978-1-68440-002-7

Edition: First

Pages: 74

CLSI C63 Additional Details

A guideline for global application developed through the Clinical and Laboratory Standards Institute consensus process.

This document was formerly sold under the code C61.

CLSI C63 Abstract

Clinical and Laboratory Standards Institute guideline C63—Laboratory Support for Pain Management Programs provides recommendations for medical laboratory toxicology-based testing services in support of the care and treatment of persons in pain management programs. This guideline discusses specimen types and collection, testing methodologies, and results reporting and interpretation. The intended users of this guideline include medical laboratory scientists and personnel, medical technologists, hospital administrators, physician office personnel, risk managers, pharmacists, and health care providers tasked with implementing pain management testing for their institutions or networks.